| Detected | Trial | Change |
|---|---|---|
| 2026-08-08 | NCT07335588 A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult… |
Trial sites expanded: 7 -> 16 locations |
| 2026-08-04 | NCT03886246 Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With… |
Sponsor changed: Boehringer Ingelheim -> LEO Pharma |
| 2026-08-04 | NCT06013969 A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP)… |
Sponsor changed: Boehringer Ingelheim -> LEO Pharma |
| 2026-08-04 | NCT06624670 A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma… |
Sponsor changed: Boehringer Ingelheim -> LEO Pharma |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06013969 | A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP)… | Generalized Pustular Psoriasis | Active, Not Recruiting |
| Phase 3 | |||
| NCT06311682 | A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical… | Atopic Dermatitis | Recruiting |
| NCT06624670 | A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma… | Pyoderma Gangrenosum | Recruiting |
| NCT07335588 | A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult… | Lichen Sclerosus | Recruiting |
| Phase 2 | |||
| NCT07013201 | A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in… | Palmoplantar Pustulosis | Recruiting |
| NCT03886246 | Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With… | Generalized Pustular Psoriasis | Active, Not Recruiting |
| Not specified | |||
| NCT07603193 | Real-World Evidence: Effectiveness and Safety of Chronic Hand Eczema Treatment With… | Chronic Hand Eczema (CHE) | Enrolling by Invitation |